| Schedule of Credit Risk for Contingent Loans |
As of December
31, 2025 and 2024, for credit risk for contingent loans is composed as follows:
| | |
Outstanding exposure | | |
ECL | |
| | |
2025 | | |
2024 | | |
2025 | | |
2024 | |
| | |
MCh$ | | |
MCh$ | | |
MCh$ | | |
MCh$ | |
| Warranty by endorsement and sureties | |
| 288,710 | | |
| 336,737 | | |
| 1,884 | | |
| 1,505 | |
| Confirmed foreign letters of credit | |
| 186,843 | | |
| 160,856 | | |
| 161 | | |
| 92 | |
| Issued foreign letters of credit | |
| 262,916 | | |
| 281,360 | | |
| 400 | | |
| 321 | |
| Performance guarantees | |
| 3,173,261 | | |
| 3,124,626 | | |
| 18,190 | | |
| 16,923 | |
| Undrawn credit lines | |
| 11,453,782 | | |
| 11,125,300 | | |
| 64,810 | | |
| 68,555 | |
| Other commitments | |
| 69,191 | | |
| 51,889 | | |
| 262 | | |
| 89 | |
| Total | |
| 15,434,703 | | |
| 15,080,768 | | |
| 85,707 | | |
| 87,485 | |
|
| Schedule of Credit Quality and the Maximum Exposure to Credit Risk Based on the Bank’s Internal Credit Rating System |
The table below shows the credit quality
and the maximum exposure to credit risk based on the Bank’s internal credit rating system and year-end stage classification as of
December 31, 2025 and 2024.
| |
|
|
As of December 31, 2025 |
|
|
|
|
|
|
As of December 31, 2024 |
|
|
|
|
| |
|
Stage 1 |
|
|
Stage 2 |
|
|
Stage 3 |
|
|
|
|
|
Stage 1 |
|
|
Stage 2 |
|
|
Stage 3 |
|
|
|
|
| |
|
Individual MCh$ |
|
|
Group MCh$ |
|
|
Individual MCh$ |
|
|
Group MCh$ |
|
|
Individual MCh$ |
|
|
Group MCh$ |
|
|
Total MCh$ |
|
|
Individual MCh$ |
|
|
Group MCh$ |
|
|
Individual MCh$ |
|
|
Group MCh$ |
|
|
Individual MCh$ |
|
|
Group MCh$ |
|
|
Total MCh$ |
|
| Normal |
|
|
5,502,166 |
|
|
|
9,569,203 |
|
|
|
11,305 |
|
|
|
292,476 |
|
|
|
— |
|
|
|
— |
|
|
|
15,375,150 |
|
|
|
5,328,378 |
|
|
|
9,397,036 |
|
|
|
19,936 |
|
|
|
262,865 |
|
|
|
— |
|
|
|
— |
|
|
|
15,008,215 |
|
| Substandard |
|
|
— |
|
|
|
— |
|
|
|
39,069 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
39,069 |
|
|
|
— |
|
|
|
— |
|
|
|
40,227 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
40,227 |
|
| Non-performing |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
13,813 |
|
|
|
6,671 |
|
|
|
20,484 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
24,503 |
|
|
|
7,823 |
|
|
|
32,326 |
|
| Total |
|
|
5,502,166 |
|
|
|
9,569,203 |
|
|
|
50,374 |
|
|
|
292,476 |
|
|
|
13,813 |
|
|
|
6,671 |
|
|
|
15,434,703 |
|
|
|
5,328,378 |
|
|
|
9,397,036 |
|
|
|
60,163 |
|
|
|
262,865 |
|
|
|
24,503 |
|
|
|
7,823 |
|
|
|
15,080,768 |
|
|
| Schedule of Changes in Outstanding Exposures and Corresponding Allowance |
An analysis of changes in the outstanding
exposures and corresponding provision for ECL during the 2025 and 2024 periods are as follows:
| | |
Stage
1 | | |
Stage
2 | | |
Stage
3 | | |
| |
| | |
Individual | | |
Group | | |
Individual | | |
Group | | |
Individual | | |
Group | | |
Total | |
| | |
Gross
carrying amount MCh$ | | |
ECL
MCh$ | | |
Gross
carrying amount MCh$ | | |
ECL
MCh$ | | |
Gross
carrying amount MCh$ | | |
ECL
MCh$ | | |
Gross
carrying amount MCh$ | | |
ECL
MCh$ | | |
Gross
carrying amount MCh$ | | |
ECL
MCh$ | | |
Gross
carrying amount MCh$ | | |
ECL
MCh$ | | |
Gross
carrying amount MCh$ | | |
ECL
MCh$ | |
| Outstanding exposure as of January
1, 2025 | |
| 5,328,378 | | |
| 10,684 | | |
| 9,397,036 | | |
| 61,028 | | |
| 60,163 | | |
| 4,923 | | |
| 262,865 | | |
| 2,460 | | |
| 24,503 | | |
| 4,748 | | |
| 7,823 | | |
| 3,642 | | |
| 15,080,768 | | |
| 87,485 | |
| Net change on exposures | |
| 271,262 | | |
| 222 | | |
| 620,577 | | |
| (1,658 | ) | |
| (3,460 | ) | |
| (1,755 | ) | |
| (79,908 | ) | |
| (279 | ) | |
| (13,302 | ) | |
| (1,788 | ) | |
| (5,786 | ) | |
| (864 | ) | |
| 789,383 | | |
| (6,122 | ) |
| Transfer to Stage 1 | |
| 45,277 | | |
| 337 | | |
| 737,007 | | |
| 8,805 | | |
| (45,220 | ) | |
| (301 | ) | |
| (734,234 | ) | |
| (7,544 | ) | |
| (57 | ) | |
| (36 | ) | |
| (2,773 | ) | |
| (1,261 | ) | |
| — | | |
| — | |
| Transfer to Stage 2 | |
| (41,967 | ) | |
| (122 | ) | |
| (862,155 | ) | |
| (6,016 | ) | |
| 42,749 | | |
| 160 | | |
| 862,400 | | |
| 6,115 | | |
| (782 | ) | |
| (38 | ) | |
| (245 | ) | |
| (99 | ) | |
| — | | |
| — | |
| Transfer to Stage 3 | |
| (94 | ) | |
| — | | |
| (619 | ) | |
| (5 | ) | |
| (3,393 | ) | |
| (100 | ) | |
| (7,306 | ) | |
| (1,507 | ) | |
| 3,487 | | |
| 100 | | |
| 7,925 | | |
| 1,512 | | |
| — | | |
| — | |
| Impact on year-end ECL of
exposures transferred between stages during the year | |
| — | | |
| (206 | ) | |
| — | | |
| (3,994 | ) | |
| — | | |
| 899 | | |
| — | | |
| 3,624 | | |
| — | | |
| 929 | | |
| — | | |
| 182 | | |
| — | | |
| 1,434 | |
| Refinements to models used
for calculation | |
| — | | |
| 4,290 | | |
| — | | |
| — | | |
| — | | |
| 108 | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 4,398 | |
| Foreign
exchange adjustments | |
| (100,690 | ) | |
| (235 | ) | |
| (322,643 | ) | |
| (1,080 | ) | |
| (465 | ) | |
| (3 | ) | |
| (11,341 | ) | |
| (42 | ) | |
| (36 | ) | |
| (18 | ) | |
| (273 | ) | |
| (110 | ) | |
| (435,448 | ) | |
| (1,488 | ) |
| Total | |
| 5,502,166 | | |
| 14,970 | | |
| 9,569,203 | | |
| 57,080 | | |
| 50,374 | | |
| 3,931 | | |
| 292,476 | | |
| 2,827 | | |
| 13,813 | | |
| 3,897 | | |
| 6,671 | | |
| 3,002 | | |
| 15,434,703 | | |
| 85,707 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Outstanding exposure as of January 1, 2024 | |
| 4,775,026 | | |
| 12,464 | | |
| 8,422,110 | | |
| 59,093 | | |
| 68,290 | | |
| 6,242 | | |
| 254,564 | | |
| 2,364 | | |
| 18,861 | | |
| 5,417 | | |
| 8,584 | | |
| 4,060 | | |
| 13,547,435 | | |
| 89,640 | |
| Net change on exposures | |
| 446,635 | | |
| (2,010 | ) | |
| 640,430 | | |
| 1,862 | | |
| (10,584 | ) | |
| (1,642 | ) | |
| (61,617 | ) | |
| (72 | ) | |
| (5,580 | ) | |
| (2,106 | ) | |
| (6,498 | ) | |
| (1,056 | ) | |
| 1,002,786 | | |
| (5,024 | ) |
| Transfer to Stage 1 | |
| 51,618 | | |
| 278 | | |
| 724,421 | | |
| 9,166 | | |
| (51,590 | ) | |
| (269 | ) | |
| (718,951 | ) | |
| (6,839 | ) | |
| (28 | ) | |
| (9 | ) | |
| (5,470 | ) | |
| (2,327 | ) | |
| — | | |
| — | |
| Transfer to Stage 2 | |
| (64,150 | ) | |
| (178 | ) | |
| (781,359 | ) | |
| (6,138 | ) | |
| 64,276 | | |
| 242 | | |
| 781,686 | | |
| 6,272 | | |
| (126 | ) | |
| (64 | ) | |
| (327 | ) | |
| (134 | ) | |
| — | | |
| — | |
| Transfer to Stage 3 | |
| (230 | ) | |
| (1 | ) | |
| (4,778 | ) | |
| (55 | ) | |
| (11,105 | ) | |
| (172 | ) | |
| (6,390 | ) | |
| (1,511 | ) | |
| 11,335 | | |
| 173 | | |
| 11,168 | | |
| 1,566 | | |
| — | | |
| — | |
| Impact on year-end ECL of
exposures transferred between stages during the year | |
| — | | |
| (137 | ) | |
| — | | |
| (4,400 | ) | |
| — | | |
| 497 | | |
| — | | |
| 2,192 | | |
| — | | |
| 1,314 | | |
| — | | |
| 1,359 | | |
| — | | |
| 825 | |
| Refinements to models used
for calculation | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | |
| Foreign
exchange adjustments | |
| 119,479 | | |
| 268 | | |
| 396,212 | | |
| 1,500 | | |
| 876 | | |
| 25 | | |
| 13,573 | | |
| 54 | | |
| 41 | | |
| 23 | | |
| 366 | | |
| 174 | | |
| 530,547 | | |
| 2,044 | |
| Total | |
| 5,328,378 | | |
| 10,684 | | |
| 9,397,036 | | |
| 61,028 | | |
| 60,163 | | |
| 4,923 | | |
| 262,865 | | |
| 2,460 | | |
| 24,503 | | |
| 4,748 | | |
| 7,823 | | |
| 3,642 | | |
| 15,080,768 | | |
| 87,485 | |
|